SequelSEC

CHEMED CORP CHE

Services-Home Health Care Services · CIK 0000019584 · Fiscal year ends 1231

Revenue
$2.60B
Fiscal year ended 2026-06-30
Operating income
$349.19M
Fiscal year ended 2026-06-30
Free cash flow
$323.61M
Fiscal year ended 2026-06-30

CHEMED CORP (CHE) reported revenue of $2.60B and net income of $274.99M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from CHEMED CORP’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Home Health Care Services.

Income

CHEMED CORP income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$2.60B
Cost of revenue$1.74B
Gross profit$859.31M
Operating income$349.19M
Net income$274.99M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income$369.16M
Income tax expense$94.16M
Diluted EPSUnavailable
Selling, general & administrative$440.80M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

CHEMED CORP balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$40.22M
Total assets$1.58B
Current assets$291.24M
Total liabilities$749.08M
Current liabilities$319.85M
Total equity incl. NCI$830.51M
Temporary (mezzanine) equityUnavailable
Inventory$7.63M
Accounts receivable$188.63M
Goodwill$699.40M
Long-term debt$140.00M
Accounts payable$84.71M

Cash flow

CHEMED CORP cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$389.95M
Capital expenditures$66.35M
Investing cash flow-$96.21M
Financing cash flow-$503.42M
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paid$33.20M
Common share repurchases$642.85M
Depreciation & amortization$66.42M

Derived

CHEMED CORP derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$323.61M
Gross margin33.1%
Operating margin13.5%
FCF margin12.5%
SBC / revenueUnavailable
Current ratio0.91x
Revenue YoY growth3.3%
Net margin10.6%
R&D / revenueUnavailable
CapEx / revenue2.6%
Long-term debt / equity0.17x
Effective tax rate25.5%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CHE in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-31View SEC filing
10-Q · Filed 2026-04-28View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-07-31View SEC filing
10-Q · Filed 2025-04-28View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.